Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Suggested SHM question - Licensing Capacity

Suggested SHM question - Licensing Capacity

posted on Oct 18, 2007 09:03AM

I will not be at the SHM but I would like to pass along my concerns. Perhaps some attendee would raise this issue at the meeting.

 

What is the estimated licensing capacity now (3 per month, 4, 5, ?), and what are the bottlenecks that prevent more rapid licensing ?

 

What is the plan to increase licensing capacity?

 

Understanding of revenue constraints and plans to meliorate them should be a key agenda item for PTSC, TPL, and Alliacense.  It seems to me that they need a substantial improvement in licensing capacity. A favorable court outcome will make capacity even more important.

 

Share
New Message
Please login to post a reply